Barotrauma Market Research Report – Forecast to 2027

Barotrauma Market Research Report: Information by Type (Ear, Sinus, Pulmonary Barotrauma), Type (Otoscopy, Pulmonary Function Test, Lung Perfusion Scan, Pulse Oximetry), Treatment (Medications, Surgery), End-User -Forecast Till 2027

ID: MRFR/Pharma/4443-HCR | August 2022 | Region: Global | 100 Pages         

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Treatment Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Barotrauma Market, by Type

6.1 Introduction

6.2 Ear Barotrauma

6.2.1 Market Estimates & Forecast, 2020–2027

6.3 Sinus Barotrauma

6.3.1 Market Estimates & Forecast, 2020–2027

6.4 Pulmonary (Lung) Barotrauma

6.4.1 Market Estimates & Forecast, 2020–2027

Chapter 7. Global Barotrauma Market, by Diagnosis

7.1 Introduction

7.2 Otoscopy

7.2.1 Market Estimates & Forecast, 2020–2027

7.3 X-ray

7.3.1 Market Estimates & Forecast, 2020–2027

7.4 Computed Tomography (CT) Scan

7.4.1 Market Estimates & Forecast, 2020–2027

7.5 Pulmonary Function Test

7.5.1 Market Estimates & Forecast, 2020–2027

7.6 Lung Perfusion Scan

7.6.1 Market Estimates & Forecast, 2020–2027

7.7 Computed Tomography (CT) Scan

7.7.1 Market Estimates & Forecast, 2020–2027

7.8 Pulmonary Function Test

7.8.1 Market Estimates & Forecast, 2020–2027

7.9 Lung Perfusion Scan

7.9.1 Market Estimates & Forecast, 2020–2027

Chapter 8. Global Barotrauma Market, by Treatment

8.1 Introduction

8.2 Pressure Relief

8.2.1 Market Estimates & Forecast, 2020–2027

8.3 Medications

8.3.1 Market Estimates & Forecast, 2020–2027

8.4 Surgery

8.4.1 Market Estimates & Forecast, 2020–2027

8.5 Oxygen Treatment

8.5.1 Market Estimates & Forecast, 2020–2027

8.6 Recompression Therapy

8.6.1 Market Estimates & Forecast, 2020–2027

8.7 Others

8.7.1 Market Estimates & Forecast, 2020–2027

Chapter 9. Global Barotrauma Market, by End-User

9.1 Introduction

9.2 Hospitals & Clinics

9.2.1 Market Estimates & Forecast, 2020–2027

9.3 Trauma Centers

9.3.1 Market Estimates & Forecast, 2020–2027

9.4 Pharmaceutical Companies

9.4.1 Market Estimates & Forecast, 2020–2027

9.5 Medical Device Companies

9.5.1 Market Estimates & Forecast, 2020–2027

9.6 Academic and Research Institutes

9.6.1 Market Estimates & Forecast, 2020–2027

9.7 Others

9.7.1 Market Estimates & Forecast, 2020–2027

Chapter 12. Global Barotrauma Market, by Region

12.1 Introduction

12.2 Americas

12.2.1 North America

12.2.1.1 U.S.

12.2.1.1 Canada

12.2.2 South America

12.3 Europe

12.3.1 Western Europe

12.3.1.1 Germany

12.3.1.2 France

12.3.1.3 Italy

12.3.1.4 Spain

12.3.1.5 U.K.

12.3.1.6 Rest of Western Europe

12.3.2 Eastern Europe

12.4 Asia Pacific

12.4.1 Japan

12.4.2 China

12.4.3 India

12.4.4 Australia

12.4.5 Republic of Korea

12.4.6 Rest of Asia Pacific

12.5 The Middle East & Africa

12.5.1 United Arab Emirates

12.5.2 Saudi Arabia

12.5.3 Oman

12.5.4 Kuwait

12.5.5 Qatar

12.5.6 Rest of the Middle East & Africa

Chapter 13 Company Landscape

13.1 Introduction

13.2 Market Share Analysis

13.3 Key Development & Strategies

13.3.1 Key Developments

Chapter 14 Company Profiles

14.1 3M

14.1.1 Company Overview

14.1.2 Types Overview

14.1.3 Financials

14.1.4 SWOT Analysis

14.2 AstraZeneca Plc

14.2.1 Company Overview

14.2.2 Types Overview

14.2.3 Financial Overview

14.2.4 Key Developments

14.2.5 SWOT Analysis

14.3 Johnson & Johnson Services, Inc.

14.3.1 Company Overview

14.3.2 Types Overview

14.3.3 Financial Overview

14.3.4 Key Development

14.3.5 SWOT Analysis

14.4 Merck

14.4.1 Company Overview

14.4.2 Types/Business Segment Overview

14.4.3 Financial Overview

14.4.4 Key Development

14.4.5 SWOT Analysis

14.5 GLAXOSMITHKLINE

14.5.1 Company Overview

14.5.2 Types Overview

14.5.3 Financial overview

14.5.4 Key Developments

14.6 Novartis AG

14.6.1 Company Overview

14.6.2 Types Overview

14.6.3 Financial Overview

14.6.4 Key Developments

14.7 HEINE

14.7.1 Overview

14.7.2 Types Overview

14.7.3 Financials

14.7.4 Key Developments

14.7.5 SWOT Analysis

14.8 Others

Chapter 15 MRFR Conclusion

15.1 Key Findings

15.1.1 From CEO’s View Point

15.1.2 Unmet Needs of the Market

15.2 Key Companies to Watch

15.3 Prediction of the Barotrauma Industry

Chapter 16 Appendix

LIST OF TABLES

Table 1 Barotrauma Industry Synopsis, 2020–2027

Table 2 Barotrauma Market Estimates & Forecast, 2020–2027, (USD Million)

Table 3 Barotrauma Market, by Region, 2020–2027, (USD Million)

Table 4 Barotrauma Market, by Type, 2020–2027, (USD Million)

Table 5 Barotrauma Market, by Diagnosis, 2020–2027, (USD Million)

Table 6 Barotrauma Market, by Treatment, 2020–2027, (USD Million)

Table 7 Barotrauma Market, by End-User, 2020–2027, (USD Million)

Table 8 North America Barotrauma Market, by Type, 2020–2027, (USD Million)

Table 9 North America Barotrauma Market, by Diagnosis, 2020–2027, (USD Million)

Table 10 North America Barotrauma Market, by Treatment, 2020–2027, (USD Million)

Table 11 North America Barotrauma Market, by End-User, 2020–2027, (USD Million)

Table 12 U.S. Barotrauma Market, by Type, 2020–2027, (USD Million)

Table 13 U.S. Barotrauma Market, by Diagnosis, 2020–2027, (USD Million)

Table 14 U.S. Barotrauma Market, by Treatment, 2020–2027, (USD Million)

Table 15 U.S. Barotrauma Market, by End-User, 2020–2027, (USD Million)

Table 16 Canada Barotrauma Market, by Type, 2020–2027, (USD Million)

Table 17 Canada Barotrauma Market, by Diagnosis, 2020–2027, (USD Million)

Table 18 Canada Barotrauma Market, by Treatment, 2020–2027, (USD Million)

Table 19 Canada Barotrauma Market, by End-User, 2020–2027, (USD Million)

Table 20 South America Barotrauma Market, by Type, 2020–2027, (USD Million)

Table 21 South America Barotrauma Market, by Diagnosis, 2020–2027, (USD Million)

Table 22 South America Barotrauma Market, by Treatment, 2020–2027, (USD Million)

Table 23 South America Barotrauma Market, by End-User, 2020–2027, (USD Million)

Table 24 Europe Barotrauma Market, by Type, 2020–2027, (USD Million)

Table 25 Europe Barotrauma Market, by Diagnosis, 2020–2027, (USD Million)

Table 26 Europe Barotrauma Market, by Treatment, 2020–2027, (USD Million)

Table 27 Europe Barotrauma Market, by End-User, 2020–2027, (USD Million)

Table 28 Western Europe Barotrauma Market, by Type, 2020–2027, (USD Million)

Table 29 Western Europe Barotrauma Market, by Diagnosis, 2020–2027, (USD Million)

Table 30 Western Europe Barotrauma Market, by Treatment, 2020–2027, (USD Million)

Table 31 Western Europe Barotrauma Market, by End-User, 2020–2027, (USD Million)

Table 32 Eastern Europe Barotrauma Market, by Type, 2020–2027, (USD Million)

Table 33 Eastern Europe Barotrauma Market, by Diagnosis, 2020–2027, (USD Million)

Table 34 Eastern Europe Barotrauma Market, by Treatment, 2020–2027, (USD Million)

Table 35 Eastern Europe Barotrauma Market, by End-User, 2020–2027, (USD Million)

Table 36 Asia Pacific Barotrauma Market, by Type, 2020–2027, (USD Million)

Table 37 Asia Pacific Barotrauma Market, by Diagnosis, 2020–2027, (USD Million)

Table 38 Asia Pacific Barotrauma Market, by Treatment, 2020–2027, (USD Million)

Table 39 Asia Pacific Barotrauma Market, by End-User, 2020–2027, (USD Million)

Table 40 The Middle East & Africa Barotrauma Market, by Type, 2020–2027, (USD Million)

Table 41 The Middle East & Africa Barotrauma Market, by Diagnosis, 2020–2027, (USD Million)

Table 42 The Middle East & Africa Barotrauma Market, by Treatment, 2020–2027, (USD Million)

Table 43 The Middle East & Africa Barotrauma Market, by End-User, 2020–2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Barotrauma Market

Figure 3 Segmentation Market Dynamics for Barotrauma Market

Figure 4 Global Barotrauma Market Share, by Type 2020

Figure 5 Global Barotrauma Market Share, by Diagnosis 2020

Figure 6 Global Barotrauma Market Share, by Treatment 2020

Figure 7 Global Barotrauma Market Share, by End-User 2020

Figure 8 Global Barotrauma Market Share, by Region, 2020

Figure 9 North America Barotrauma Market Share, by Country, 2020

Figure 10 Europe Barotrauma Market Share, by Country, 2020

Figure 11 Asia Pacific Barotrauma Market Share, by Country, 2020

Figure 12 Middle East & Africa Barotrauma Market Share, by Country, 2020

Figure 13 Global Barotrauma market: Company Share Analysis, 2020 (%)

Figure 14 3M: Key Financials

Figure 15 3M: Segmental Revenue

Figure 16 3M: Geographical Revenue

Figure 17 AstraZeneca plc: Key Financials

Figure 18 AstraZeneca plc: Segmental Revenue

Figure 19 AstraZeneca plc: Geographical Revenue

Figure 20 Johnson & Johnson Services, Inc.: Key Financials

Figure 21 Johnson & Johnson Services, Inc.: Segmental Revenue

Figure 22 Johnson & Johnson Services, Inc.: Geographical Revenue

Figure 23 Merck: Key Financials

Figure 24 Merck: Segmental Revenue

Figure 25 Merck: Geographical Revenue

Figure 26 GLAXOSMITHKLINE: Key Financials

Figure 27 GLAXOSMITHKLINE: Segmental Revenue

Figure 28 GLAXOSMITHKLINE Geographical Revenue

Figure 29 Novartis AG: Key Financials

Figure 30 Novartis AG: Segmental Revenue

Figure 31 Novartis AG: Geographical Revenue

Figure 32 HEINE: Key Financials

Figure 33 HEINE: Segmental Revenue

Figure 34 HEINE: Geographical Revenue

Barotrauma Market Speak to Analyst Request a Free Sample

Barotrauma Market Scenario


Barotrauma is the pain or discomfort that is felt when there is a difference in air pressure between the body and the outside environment. Barotrauma can affect the ear, sinuses, and lungs and barotrauma of the ear is quite common. Ear barotrauma is caused when the eustachian tube gets blocked, and the body is not able to equalize the air pressure. The condition is usually not severe and is easily treatable, but there are few complications associated with it, such as loss of hearing, perforated (punctured) eardrum, and ear infection. Pulmonary barotrauma occurs when outside pressure is different from the pressure of the air in the lungs. Scuba divers usually face this problem as they swim underwater with the help of canisters of compressed air. While diving, if a diver inhales too much-compressed air and ascends without properly exhaling, then the lungs may overinflate which could lead to the collapse of lungs.


The most common symptoms associated with barotrauma are a pain in ears, hearing loss (temporary), nasal bleeding, headaches, sinus pressure, chest pain, shortness of breath, decompression sickness, hoarseness, pneumothorax, seizures, coughing up blood, partial paralysis, and others.


It is noted that the increasing cases of ear barotrauma, technological advancements, and increasing healthcare expenditure are the key factors driving the barotrauma market.


Various other factors such as the growing awareness about barotrauma, increasing cases of injuries while scuba diving, unmet medical needs, enhancing regulatory framework, increasing government assistance, and increasing funding and reimbursement are continuously contributing to the growth of the barotrauma market.


Despite these drivers, there are some setbacks associated with the barotrauma market. Strict FDA regulations, huge capital investments with low-profit margins, and poor healthcare system in low and middle-income countries may hinder the growth of the barotrauma market to a considerable extent.


It is estimated that the barotrauma market is expected to have a CAGR of 6.5% during the forecast period of 2017–2023.


Research Methodology


 barotrauma market


Sources: Annual reports, Press release, White paper, and Company presentation


Intended Audience



  • Pharmaceutical Companies

  • Research and Development (R&D) Companies

  • Diagnostic Laboratories

  • Government Research Institutes

  • Academic Institutes and Universities


Segmentation


The barotrauma market is segmented by type, diagnosis, treatment, and end-user.


On the basis of type, the barotrauma market is classified as ear barotrauma, sinus barotrauma, and pulmonary (lung) barotrauma.


On the basis of diagnosis, the barotrauma market is classified as otoscopy, X-ray, Computed Tomography (CT) scan, pulmonary function test, lung perfusion scan, Magnetic Resonance Imaging (MRI), pulse oximetry, and others.


On the basis of treatment, the barotrauma market is classified as pressure relief, medications, surgery, oxygen treatment, recompression therapy, others. The medications segment is further classified as decongestant nasal sprays, oral decongestants, oral antihistamines, painkillers, antibiotics, and others. The surgery segment is further classified as Functional Endoscopic Sinus Surgery (FESS), tympanostomy, Single Laparoscopic Incision Transabdominal (SLIT), and others.


On the basis of end-user, the barotrauma market is segmented into hospitals and clinics, trauma centers, pharmaceutical companies, medical device companies, academic and research institutes, and others.


Regional Analysis


The Americas dominates the barotrauma market owing to the increasing prevalence of ear barotrauma and high healthcare expenditure.


Europe holds the second position in the barotrauma market. The financial support provided by the government towards R&D and technological advancements are expected to drive the European barotrauma market. The increasing healthcare expenditure is also boosting the European barotrauma market.


According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014, i.e., EUR 321 billion which is further followed by France with EUR 237 billion and United Kingdom with EUR 223 billion. In 2016, the R&D expenditure in the pharmaceutical industry was EUR 35000 million, suggested by the European Federation of Pharmaceutical Industries and Association.


Asia Pacific is the fastest growing barotrauma market owing to a huge patient pool and development in the pharmaceutical sector. Healthcare expenditure is found to be boosting in various regions of Asia Pacific. As per the data suggested by the Australian Institute of Health and Welfare during the year 2015–2016, the total health expenditure was nearly USD 170.4 billion, i.e., 3.6% higher than the expenditure of 2014–2015.


The Middle East and Africa holds the lowest share of the global market due to slow development, lack of technical knowledge, and poor medical facilities.


Key Players


Some of the key players in the barotrauma market are 3M, Accurate Surgical & Scientific Instruments Corporation, AptarGroup, AstraZeneca plc., Atos Medical, CellScope, Entellus Medical Inc., GlaxoSmithKline plc, HEINE, Inventis, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Olympus Corporation, Pfizer, Inc., Cipla Ltd., Mylan N.V., Preceptis Medical, Rudolf Riester GmbH, Shanghai Yuejin, SinuSys Corporation, Teva Pharmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., Sklar Surgical Instruments, Smith & Nephew Plc, Valeant pharmaceuticals International Inc., Hill-Rom, and others.



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   6.5% (2017-2023)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Diagnosis, Treatment, and End-user
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   3M, Accurate Surgical & Scientific Instruments Corporation, AptarGroup, AstraZeneca plc., Atos Medical, CellScope, Entellus Medical Inc., GlaxoSmithKline plc, HEINE, Inventis, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Olympus Corporation, Pfizer, Inc., Cipla Ltd., Mylan N.V., Preceptis Medical, Rudolf Riester GmbH, Shanghai Yuejin, SinuSys Corporation, Teva Pharmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., Sklar Surgical Instruments, Smith & Nephew Plc, Valeant pharmaceuticals International Inc., Hill-Rom, and others.
  Key Market Opportunities

  • Growing awareness about barotrauma
  • Increasing cases of injuries while scuba diving
  • Unmet medical needs
  • Enhancing regulatory framework
  • Increasing government assistance
  • Increasing funding and reimbursement
  •   Key Market Drivers

  • Increasing cases of ear barotrauma
  • Technological advancements
  • Increasing healthcare expenditure


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Barotrauma is the pain or discomfort felt when there is a difference in air pressure between the body and the outside environment. Barotrauma can affect the ear, sinuses, and lungs – barotrauma of the ear is quite common.

    Barotrauma Market is expected to exhibit a strong 6.5% CAGR over the forecast period from 2020 to 2027.

    The increasing prevalence of ear barotrauma is the major driver for the Barotrauma Market.

    The Americas dominate the Global Barotrauma Market.

    Leading players in the barotrauma market include 3M, GSK, and Inventis, among others.